Holding(s) in Company
Michael Anthony Ashcroft has increased his holding in Optima Health plc, with his voting rights now standing at 27.59% of the total 108,775,375 voting rights, up from a previous holding of 24.0%. This notification is due to an acquisition of voting rights related to the company's open offer, with the change occurring on April 24, 2026, and reported on April 27, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your OPT notes
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : | Optima Health plc |
- Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
| Other (please specify) iii : Basic entitlement and excess application for the company open offer | X |
Details of person subject to the notification obligation iv
| Name | Michael Anthony Ashcroft |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 04/24/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 04/27/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 27.59% | 27.59% | 108,775,375 |
| Position of previous notification (if applicable) | 24.0% | 24.0% | |
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
| GB00BRSCY602 | 30,010,288 | 27.59% | |
| SUBTOTAL 8. A | 30,010,288 | 27.59% | |
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
SUBTOTAL 8. B 1
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | Belize |
| Date of completion | 27 th April 2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.